NeuroBio
  • Home
  • About Us
    • Our Science
    • Our Pipeline
    • Neuro-Bio Assets
  • Our People
    • Board
    • Management
    • Science Team
    • Science Advisory Board
    • Company Organogram
  • Publications
  • Investors
    • Hear from our Investors
    • FAQ’s
  • News
    • Supporters
  • Work With Us
    • Careers
    • Industrial Placements
  • Contact
Select Page
New Publication: Evaluating Monoclonal Antibodies in Alzheimer’s Disease Research

New Publication: Evaluating Monoclonal Antibodies in Alzheimer’s Disease Research

We are pleased to announce the publication of our latest paper, “Evaluating the Efficacy of Monoclonal Antibodies Against a Bioactive Peptide Involved in Alzheimer’s Disease: A Methodological Approach.” The paper outlines a methodological framework for assessing...

LATEST NEWS

  • New Publication: Evaluating Monoclonal Antibodies in Alzheimer’s Disease Research
  • Neuro-Bio’s first paper of 2026 has been published!
  • Jo Hayman from Rathbones (UK-based investment and wealth management company) visits Neuro-Bio!
  • CEO and Founder Baroness Greenfield and CSO Dr Sara Garcia Ratés meet with Dalloway Partners to discuss pioneering science and innovative ventures
  • CEO & Founder Baroness Susan Greenfield visits San Raffaele Hospital in Milan!

TOPICS

  • Latest News
  • Media
  • Publications

© Neuro-Bio 2025

  • Instagram
© Neuro-Bio 2025